Gabriel Morris - May 20, 2024 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CFO, Director
Signature
/s/ Gabriel Morris
Stock symbol
IMMX
Transactions as of
May 20, 2024
Transactions value $
$0
Form type
4
Date filed
5/20/2024, 05:25 PM
Previous filing
May 14, 2024
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMMX Common Stock Award +194K +226.32% 280K May 20, 2024 Direct F1
transaction IMMX Common Stock Award +24.1K +9.79% 271K May 20, 2024 See footnote F1, F2
transaction IMMX Common Stock Award +24.1K 24.1K May 20, 2024 See footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity.
F2 Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
F3 Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.